In a 2011 retrospective study, Jayasena and colleagues found that patients with prolonged exposure to elevated IGF-1 and GH levels were more likely to have diagnoses of impaired glucose tolerance, cardiovascular system disorders, and diabetes compared to those with a lesser cumulative biochemical burden [17]. This evidence concerns the gene GH1 and Impaired glucose tolerance.